Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...

Tri-Union Seafoods issued the voluntary recall on the products Friday out of "an abundance of caution" over botulism risk.

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

All the latest news as Pep Guardiola speaks to the media before Manchester City's Champions League play-off match against ...

She left the agency saying politics had slowed the approval of the morning-after pill for over-the-counter use. Her resignation drew national attention. By Trip Gabriel Susan F. Wood, a women’s ...

The data that resulted in the FDA approval for zenocutuzumab with NRG1 fusions came from an international clinical trial led by Dr. Schram, called the eNRGy study. Data from 158 patients were included ...

But a new non-opioid pain medication, which was just approved by the FDA, could help change that. “80 million people suffer from acute pain, whether from surgery, trauma, or other injuries,” said ...

Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...

Canada’s Foreign Minister Melanie Joly warned that proposed U.S. tariffs could force America to rely on Venezuelan oil imports, as tensions escalate ahead of President Donald Trump‘s planned ...

The drug is suzetrigine under the brand name Journavx. It is now FDA-approved to treat moderate to severe acute pain, which is usually caused by injury, trauma or surgery. Pain is registered in ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s diabetes-cum-weight loss drug Ozempic for patients with both chronic kidney disease (CKD) and diabetes after clinical trials ...